CDC/AHA Workshop on Markers of Inflammation and Cardiovascular Disease - Application to Clinical and Public Health Practice - Report from the population science discussion group

被引：53

作者：

Fortmann, SP ^{[1
]}

Ford, E ^{[1
]}

Criqui, MH ^{[1
]}

Folsom, AR ^{[1
]}

Harris, TB ^{[1
]}

Hong, YL ^{[1
]}

Pearson, TA ^{[1
]}

Siscovick, D ^{[1
]}

Vinicor, F ^{[1
]}

Wilson, PF ^{[1
]}

机构：

[1] Amer Heart Assoc, Publ Informat, Dallas, TX 75231 USA

来源：

CIRCULATION | 2004年 / 110卷 / 25期

关键词：

AHA Scientific Statements; atherosclerosis; inflammation; population risk; factors;

D O I：

10.1161/01.CIR.0000148982.95775.BF

中图分类号：

R5 [内科学];

学科分类号：

1002 [临床医学]; 100201 [内科学];

摘要：

This article summarizes epidemiological studies of inflammation markers, particularly C-reactive protein, and cardiovascular disease as of early 2002. Gaps in the research and the public health practice implications are also discussed. Although considerable work has been published since this review was completed, the perspectives and issues presented are still useful in evaluating the use of inflammation markers for risk stratisfication and prevention.

引用

页码：E554 / E559

页数：6

共 31 条

[1]

Prothrombin fragment 1+2 is a risk factor for myocardial infarction in treated hypertensive men [J].

Agewall, S ;

Wikstrand, J ;

Fagerberg, B .

JOURNAL OF HYPERTENSION, 1998, 16 (04) :537-541

[2]

Prospective study of C-reactive protein, homocysteine, and plasma lipid levels as predictors of sudden cardiac death [J].

Albert, CM ;

Ma, J ;

Rifai, N ;

Stampfer, MJ ;

Ridker, PM .

CIRCULATION, 2002, 105 (22) :2595-2599

[3]

Low grade inflammation and coronary heart disease: prospective study and updated meta-analyses [J].

Danesh, J ;

Whincup, P ;

Walker, M ;

Lennon, L ;

Thomson, A ;

Appleby, P ;

Gallimore, JR ;

Pepys, MB .

BMJ-BRITISH MEDICAL JOURNAL, 2000, 321 (7255) :199-204

[4]

Association of fibrinogen, C-reactive protein, albumin, or leukocyte count with coronary heart disease - Meta-analyses of prospective studies [J].

Danesh, J ;

Collins, R ;

Appleby, P ;

Peto, R .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1998, 279 (18) :1477-1482

[5]

de Maat M P, 2001, Ital Heart J, V2, P189

[6]

C-Reactive protein and incident coronary heart disease in the Atherosclerosis Risk In Communities (ARIC) study [J].

Folsom, AR ;

Aleksic, N ;

Catellier, D ;

Juneja, HS ;

Wu, KK .

AMERICAN HEART JOURNAL, 2002, 144 (02) :233-238

[7]

Tissue-type plasminogen activator and C-reactive protein in acute coronary heart disease. A nested case-control study [J].

Gram, J ;

Bladbjerg, EM ;

Moller, L ;

Sjol, A ;

Jespersen, J .

JOURNAL OF INTERNAL MEDICINE, 2000, 247 (02) :205-212

[8]

C-reactive protein is a strong but nonspecific risk factor of fatal stroke in elderly persons [J].

Gussekloo, J ;

Schaap, MCL ;

Frölich, M ;

Blauw, GJ ;

Westendorp, RGJ .

ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2000, 20 (04) :1047-1051

[9]

Associations of elevated interleukin-6 and C-reactive protein levels with mortality in the elderly [J].

Harris, TB ;

Ferrucci, L ;

Tracy, RP ;

Corti, MC ;

Wacholder, S ;

Ettinger, WH ;

Heimovitz, H ;

Cohen, HJ ;

Wallace, R .

AMERICAN JOURNAL OF MEDICINE, 1999, 106 (05) :506-512

[10]

von Willebrand factor, C-reactive protein, and 5-year mortality in diabetic and nondiabetic subjects - The Hoorn study [J].

Jager, A ;

van Hinsbergh, VWM ;

Kostense, PJ ;

Emeis, JJ ;

Yudkin, JS ;

Nijpels, G ;

Dekker, JM ;

Heine, RJ ;

Bouter, LM ;

Stehouwer, CDA .

ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 1999, 19 (12) :3071-3078

← 1 2 3 4 →